The National Committee for Pharmaceutical Industries (NCPI), associated with Federation of Saudi Chambers, is teaming up with proficient authorities to think about boosting logistical treatments to guarantee the constant supply chains of pharmaceutical markets in Saudi Arabia.
According to Al-Eqtisadiah paper, this effort is a preemptive step versus any prospective effects of disturbances in basic material products to the regional sector, whether through the Red Sea or Bab Al Mandab strait, provided the geopolitical stress in the area.
The committee carried out a study including 13 specialized business in the production and circulation of pharmaceuticals in the Saudi market. It suggested the requirement of supporting supply chains in the regional pharmaceutical markets by checking out alternative providers of basic materials from varied geographical areas. This intends to decrease the threats related to depending on restricted sources and increase stock levels of vital basic materials. Furthermore, the committee proposed the facility of a database for providers.
On the other hand, the Food and Drug Authority mentioned that there is no lack of basic material products for pharmaceutical production. It verified its constant interaction with business, producers, and appropriate entities to guarantee accessibility and sustainability.
On the other hand, the Saudi Food and Drug Authority (SFDA) rejected any scarcity in the raw products needed for pharmaceutical production.